Ensysce Biosciences, Inc. (ENSC) Form 8-K — May 22, 2026
Ensysce Biosciences, Inc. (ENSC) received a formal notice from Nasdaq on May 21, 2026, stating that the company is subject to delisting due to non-compliance with the $2.5 million stockholders’ equity requirement as of March 31, 2026. The company has 45 days, until July 6, 2026, to submit a plan to regain compliance. If the plan is accepted, Ensysce may be granted an extension of up to 180 days from the notice date to evidence compliance.
Key figures
- Potential extension period
- 180 days
- Stockholders equity requirement
- $2.5 million
- Compliance deadline plan submission
- July 6, 2026
Price after filing
1 day: 0.0%7 days: -6.8%30 days: -16.0%
Close on the filing date to close N calendar days later (from $0.32). Historical, not a forecast.
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.